Analyser, I tend agree with your comment "This hasn't hit the radar yet of a number of people." Certainly institutional investment is fair light with only a couple on board at this point in time, something that could change in the not too distant fututre if TOX continue to deliver the goods.
I see two basic reasons for this: 1. Depending on the investment constitution a minimum market cap is usually required - e.g. it could be $50m. TOX's market cap is sitting at $60m, but it may be a case of proving to be at least stable or improving for funds to be attracted. 2. Performance consistency - institutions need to see more than one good result in isolation. The more positive results that TOX puts out the more attention it will receive. Meeting and exceeding performance guidelines are critical.
I'm sure the half yearly will have a few peple crunching numbers in the back office.
TOX Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
